CVX
29
-2
BWA
55
2
APD
52
2
CL
62
-2
DUK
55
-2
CMA
67
2
BDX
61
2
C
81
-4
ALL
57
-3
CVS
43
2
AN
50
-2
BK
72
-2
AVGO
45
3
EBAY
56
2
ADT
50
2
CA
36
12
CCL
82
-4
CHRW
76
-3
AES
57
2
CAT
69
11
CVX
29
-2
BWA
55
2
APD
52
2
CL
62
-2
DUK
55
-2
CMA
67
2
BDX
61
2
C
81
-4
ALL
57
-3
CVS
43
2
AN
50
-2
BK
72
-2
AVGO
45
3
EBAY
56
2
ADT
50
2
CA
36
12
CCL
82
-4
CHRW
76
-3
AES
57
2
CAT
69
11
Financhill
Back

Taysha Gene Therapies, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
66

TSHA
Taysha Gene Therapies, Inc.

Last Price:
$5.85
Seasonality Move:
-17.85%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Buy
66
Taysha Gene Therapies, Inc. (TSHA) is a Buy

Is Taysha Gene Therapies, Inc. a Buy, Sell or Hold?

  • The current Taysha Gene Therapies, Inc. [TSHA] share price is $5.83. The Score for TSHA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • TSHA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TSHA Stock Price Chart

What is Taysha Gene Therapies, Inc.'s stock price today?

  • The Taysha Gene Therapies, Inc. share price today is $5.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TSHA is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $39.6400
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.

TSHA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.57 Buy
Relative Strength Index (14 RSI): 62.46 Buy
Chaikin Money Flow: 300862 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.54 - 5.78) Buy
Bollinger Bands (100): (3.09 - 5.13) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.28 Buy
Relative Strength Index (14 RSI): 66.31 Buy
Chaikin Money Flow: -583105 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.9202 - 36.9202) Buy
Bollinger Bands (100): (20.9405 - 34.5405) Buy

TSHA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.69 Buy
20-day SMA: 5.35 Buy
50-day SMA: 4.83 Buy
200-day SMA: 3.16 Buy
8-day EMA: 4.76 Buy
20-day EMA: 2.87 Buy
50-day EMA: 1.39 Buy
200-day EMA: 0.38 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.31 Buy
20-day SMA: 35.4 Buy
50-day SMA: 33.69 Buy
200-day SMA: 22.3 Buy
8-day EMA: 30.99 Buy
20-day EMA: 18.54 Buy
50-day EMA: 8.93 Buy
200-day EMA: 2.46 Buy

Taysha Gene Therapies, Inc. Earnings Growth & TSHA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.10 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Taysha Gene Therapies, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):